financetom
Business
financetom
/
Business
/
Ormat Technologies Begins Commercial Operations at Lower Rio Facility
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ormat Technologies Begins Commercial Operations at Lower Rio Facility
Sep 2, 2025 6:50 AM

09:25 AM EDT, 09/02/2025 (MT Newswires) -- Ormat Technologies ( ORA ) said Tuesday that it has begun commercial operations at its Lower Rio energy storage facility in Texas.

The battery storage facility, which has a 60 megawatt or 120 megawatt-hour capacity, will provide energy and ancillary services under a seven-year tolling agreement, the company said.

Including the Lower Rio facility, the company said it now has a total capacity of 350MW or 778MWh in the US.

The company also said it has recently signed a hybrid tax equity partnership with Morgan Stanley's ( MS ) renewables entity to monetize the 40% investment tax credits for which the Lower Rio facility is eligible. The monetization yielded $25 million in proceeds, it said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertical Aerospace Secures $50 Million Funding Commitment From Primary Creditor and Majority Shareholder
Vertical Aerospace Secures $50 Million Funding Commitment From Primary Creditor and Majority Shareholder
Nov 25, 2024
07:03 AM EST, 11/25/2024 (MT Newswires) -- Vertical Aerospace ( EVTWF ) said Monday it has secured a $50 million funding commitment from primary creditor Mudrick Capital Management and its majority shareholder, Stephen Fitzpatrick who will remain on the board of the company. The funding will support the newly launched Flightpath 2030 Strategy, focusing on its eVTOL market leadership and...
GSK Cancer Therapy Candidate Accepted for FDA Review
GSK Cancer Therapy Candidate Accepted for FDA Review
Nov 25, 2024
07:03 AM EST, 11/25/2024 (MT Newswires) -- GSK (GSK) said Monday that the US Food and Drug Administration has accepted to review a Biologics License Application for its experimental combination therapy to treat multiple myeloma patients who have received at least one prior line of treatment. The company said the application is based on a phase 3 study of blenrep...
Macy's delays Q3 report on accounting issue, sales misses in preliminary results
Macy's delays Q3 report on accounting issue, sales misses in preliminary results
Nov 25, 2024
(Reuters) - Macy's on Monday delayed publication of its third-quarter results after discovering an accounting issue related to delivery expenses and instead reported preliminary results in which its sales missed Wall Street expectations. Net sales fell 2.4% to $4.74 billion compared to analysts' average estimate of $4.77 billion, as steep promotions failed to attract customers who have turned selective on...
Macy's delays Q3 report on accounting issue, sales misses in preliminary results
Macy's delays Q3 report on accounting issue, sales misses in preliminary results
Nov 25, 2024
(Reuters) - Macy's on Monday delayed publication of its third-quarter results after discovering an accounting issue related to delivery expenses and instead reported preliminary results in which its sales missed Wall Street expectations. Net sales fell 2.4% to $4.74 billion compared to analysts' average estimate of $4.77 billion, as steep promotions failed to attract customers who have turned selective on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved